Latest Breaking News On - Masoud tavazoie - Page 1 : comparemela.com

Inspirna raises funds to advance clinical stage cancer drugs development

Inspirna has raised $50m in Series D financing round to advance the development of its clinical stage cancer drugs. New investors Sands Capital

Inspirna Raises $50 Million in Series D Financing

Inspirna Raises $50M in Series D Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Inspirna to Present Phase 1b RGX-202-01 Clinical Trial Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

Press release content from Business Wire. The AP news staff was not involved in its creation.

Inspirna to Present at 21st Annual Needham Virtual Healthcare Conference

NEW YORK (BUSINESS WIRE) Inspirna, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and biologic cancer therapeutics, announced today that CEO Masoud Tavazoie, M.D., Ph.D., will present at the 21st Annual Needham Virtual Healthcare Conference at 10:15 A.M. EST on April 14,.